Skip to content

Clinical trials

Phase 1/2 Cardiomyopathies trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathies Phase: Phase 1/2 Country / region: United States Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20142
20151
20162
20201
20211
20221
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting2
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Lexeo Therapeutics2
Mayo Clinic2
Abramson Cancer Center at Penn Medicine1
Atrium Therapeutics1
Celladon Corporation1
Craig McDonald, MD1
Horng Chen1
Thomas Advanced Medical LLC1
Washington University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathies11
Heart Failure3
Cardiovascular Diseases2
Heart Diseases2
Renal Insufficiency2
Alzheimer Disease1
Arrhythmogenic Right Ventricular Dysplasia1
Autoimmune Diseases1
Brain Diseases1
Breast Neoplasms1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.